NCT05180344 Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Open Trial (2)
| NCT ID | NCT05180344 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Butler Hospital |
| Condition | Suicide |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2024-07-25 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2024-07-25 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of this grant is to conduct pilot testing on a novel personalized mobile intervention for suicide - Mobile Application to Prevent Suicide (MAPS) - and to establish feasibility, acceptability, safety, and primary outcomes (i.e., suicidal ideation and behavior; re-hospitalization).
Eligibility Criteria
Inclusion Criteria: * Suicidal ideation and/or suicidal behavior in the past month verified by the C-SSRS * Between the ages of 18 and 26 * English proficiency * Comfortable with smartphone technology * Deemed by the treatment team to be stable enough to complete study procedures Exclusion Criteria: * Current psychotic or manic symptoms severe enough to interfere with study procedures
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05180344 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 26 Years, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05180344 currently recruiting?
Yes, NCT05180344 is actively recruiting participants. Contact the research team at ccordeiro@butler.org for enrollment information.
Where is the NCT05180344 trial being conducted?
This trial is being conducted at Providence, United States.
Who is sponsoring the NCT05180344 clinical trial?
NCT05180344 is sponsored by Butler Hospital. The trial plans to enroll 10 participants.